The pandemic has turbocharged pharma’s remote interactions with healthcare professionals (HCPs) - but accelerated deployment of new digital channels without a comprehensive customer-centric strategy or clear internal operating model that backs these initiatives could result in “disjointed” experiences, industry experts have warned.
Digital Acceleration And ‘Broken’ Customer Experience: What Pharma Should Look Out For
Biopharma experts discuss at a summit core issues around ensuring that fast-paced digital acceleration does not jeopardize the overall experience of healthcare professionals. Clarity about customer needs/behaviors, embracing a fail-fast, learn-fast mindset and measuring customer experience were among the aspects touched upon.
More from Business
More from Scrip
• By
The pact could be worth more than $2.6bn and adds to growing big pharma investment in the technology.
• By
Following the near-total dominance of IgG antibodies, the UK group is backing the potential of IgA and IgE-based therapies to transform cancer treatment with the purchase of US-headquartered TigaTx.
• By
Bharat Biotech is the latest entrant in India’s cell and gene therapy space, joining majors like Intas Pharma, Sun Pharma, Cipla and Dr. Reddy’s. An indigenously developed CAR-T cell therapy launched last year, what is driving growing interest and success in cell and gene therapies?